<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39338420</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Retrospective Analysis of Omicron in Minas Gerais, Brazil: Emergence, Dissemination, and Diversification.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1745</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms12091745</ELocationID><Abstract><AbstractText>Brazil is one of the countries most affected by COVID-19, with the highest number of deaths recorded. Brazilian Health Institutions have reported four main peaks of positive COVID-19 cases. The last two waves were characterized by the emergence of the VOC Omicron and its sublineages. This study aimed to conduct a retrospective surveillance study illustrating the emergence, dissemination, and diversification of the VOC Omicron in 15 regional health units (RHUs) in MG, the second most populous state in Brazil, by combining epidemiological and genomic data. A total of 5643 confirmed positive COVID-19 samples were genotyped using the panels TaqMan SARS-CoV-2 Mutation and 4Plex SC2/VOC Bio-Manguinhos to define mutations classifying the BA.1, BA.2, BA.4, and BA.5 sublineages. While sublineages BA.1 and BA.2 were more prevalent during the third wave, BA.4 and BA.5 dominated the fourth wave in the state. Epidemiological and viral genome data suggest that age and vaccination with booster doses were the main factors related to clinical outcomes, reducing the number of deaths, irrespective of the Omicron sublineages. Complete genome sequencing of 253 positive samples confirmed the circulation of the BA.1, BA.2, BA.4, and BA.5 subvariants, and phylogenomic analysis demonstrated that the VOC Omicron was introduced through multiple international events, followed by transmission within the state of MG. In addition to the four subvariants, other lineages have been identified at low frequency, including BQ.1.1 and XAG. This integrative study reinforces that the evolution of Omicron sublineages was the most significant factor driving the highest peaks of positive COVID-19 cases without an increase in more severe cases, prevented by vaccination boosters.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fonseca</LastName><ForeName>Paula Luize Camargos</ForeName><Initials>PLC</Initials><Identifier Source="ORCID">0000-0002-8103-9235</Identifier><AffiliationInfo><Affiliation>Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braga-Paz</LastName><ForeName>Isabela</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Araújo E Santos</LastName><ForeName>Luiza Campos Guerra</ForeName><Initials>LCG</Initials><AffiliationInfo><Affiliation>Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dias</LastName><ForeName>Rillery Calixto</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Souza</LastName><ForeName>Carolina Senra Alves</ForeName><Initials>CSA</Initials><AffiliationInfo><Affiliation>Subsecretaria de Vigilância em Saúde, Secretaria de Estado de Saúde de Minas Gerais, Belo Horizonte 31585-200, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Nara Oliveira</ForeName><Initials>NO</Initials><Identifier Source="ORCID">0000-0002-4564-2045</Identifier><AffiliationInfo><Affiliation>Núcleo de Ações e Pesquisa em Apoio Diagnóstico-Nupad, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Queiroz</LastName><ForeName>Daniel Costa</ForeName><Initials>DC</Initials><Identifier Source="ORCID">0000-0002-6607-8818</Identifier><AffiliationInfo><Affiliation>Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alves</LastName><ForeName>Hugo José</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Araújo</LastName><ForeName>João Locke Ferreira</ForeName><Initials>JLF</Initials><Identifier Source="ORCID">0000-0001-9469-9673</Identifier><AffiliationInfo><Affiliation>Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreira</LastName><ForeName>Filipe Romero Rebello</ForeName><Initials>FRR</Initials><AffiliationInfo><Affiliation>Departamento de Genetica, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menezes</LastName><ForeName>Mariane Talon</ForeName><Initials>MT</Initials><Identifier Source="ORCID">0000-0002-1042-2990</Identifier><AffiliationInfo><Affiliation>Departamento de Genetica, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menezes</LastName><ForeName>Diego</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9603-455X</Identifier><AffiliationInfo><Affiliation>Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Aryel Beatriz Paz E</ForeName><Initials>ABPE</Initials><AffiliationInfo><Affiliation>Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Jorge Gomes Goulart</ForeName><Initials>JGG</Initials><AffiliationInfo><Affiliation>Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adelino</LastName><ForeName>Talita Emile Ribeiro</ForeName><Initials>TER</Initials><AffiliationInfo><Affiliation>Fundacao Ezequiel Dias (FUNED), Belo Horizonte 30510-010, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernardes</LastName><ForeName>André Felipe Leal</ForeName><Initials>AFL</Initials><AffiliationInfo><Affiliation>Fundacao Ezequiel Dias (FUNED), Belo Horizonte 30510-010, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carobin</LastName><ForeName>Natália Virtude</ForeName><Initials>NV</Initials><AffiliationInfo><Affiliation>Laboratório Institucional de Pesquisa em Biomarcadores, Laboratório de Hematologia Clínica, Departamento de Análises Clínicas e Toxicológicas; Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Renée Silva</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Subsecretaria de Vigilância em Saúde, Secretaria de Estado de Saúde de Minas Gerais, Belo Horizonte 31585-200, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Carolina Zaniboni</ForeName><Initials>CZ</Initials><Identifier Source="ORCID">0000-0001-8817-4774</Identifier><AffiliationInfo><Affiliation>Subsecretaria de Vigilância em Saúde, Secretaria de Estado de Saúde de Minas Gerais, Belo Horizonte 31585-200, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guimarães</LastName><ForeName>Natália Rocha</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Fundacao Ezequiel Dias (FUNED), Belo Horizonte 30510-010, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamounier</LastName><ForeName>Ludmila Oliveira</ForeName><Initials>LO</Initials><AffiliationInfo><Affiliation>Fundacao Ezequiel Dias (FUNED), Belo Horizonte 30510-010, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souza</LastName><ForeName>Fernanda Gil</ForeName><Initials>FG</Initials><AffiliationInfo><Affiliation>Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vargas</LastName><ForeName>Luisa Aimeé</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Subsecretaria de Vigilância em Saúde, Secretaria de Estado de Saúde de Minas Gerais, Belo Horizonte 31585-200, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Marisa de Oliveira</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Institute of Technology in Immunobiology Bio-Manguinhos, Oswaldo Cruz Foundation/Fiocruz, Rio de Janeiro 21040-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arruda</LastName><ForeName>Monica Barcellos</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Institute of Technology in Immunobiology Bio-Manguinhos, Oswaldo Cruz Foundation/Fiocruz, Rio de Janeiro 21040-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvarez</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Technology in Immunobiology Bio-Manguinhos, Oswaldo Cruz Foundation/Fiocruz, Rio de Janeiro 21040-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreira</LastName><ForeName>Rennan Garcias</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Oliveira</LastName><ForeName>Eneida Santos</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Secretaria Municipal de Saúde de Belo Horizonte, Belo Horizonte 30130-012, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabino</LastName><ForeName>Adriano de Paula</ForeName><Initials>AP</Initials><Identifier Source="ORCID">0000-0001-8562-8689</Identifier><AffiliationInfo><Affiliation>Laboratório Institucional de Pesquisa em Biomarcadores, Laboratório de Hematologia Clínica, Departamento de Análises Clínicas e Toxicológicas; Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Oliveira</LastName><ForeName>Jaqueline Silva</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Subsecretaria de Vigilância em Saúde, Secretaria de Estado de Saúde de Minas Gerais, Belo Horizonte 31585-200, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Januário</LastName><ForeName>José Nélio</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Núcleo de Ações e Pesquisa em Apoio Diagnóstico-Nupad, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iani</LastName><ForeName>Felipe Campos de Melo</ForeName><Initials>FCM</Initials><AffiliationInfo><Affiliation>Fundacao Ezequiel Dias (FUNED), Belo Horizonte 30510-010, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souza</LastName><ForeName>Renan Pedra de</ForeName><Initials>RP</Initials><Identifier Source="ORCID">0000-0002-9479-4432</Identifier><AffiliationInfo><Affiliation>Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguiar</LastName><ForeName>Renato Santana</ForeName><Initials>RS</Initials><Identifier Source="ORCID">0000-0001-5180-3717</Identifier><AffiliationInfo><Affiliation>Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto D'OR de Pesquisa e Ensino, Rio de Janeiro 22281-100, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>01.22.0074.00</GrantID><Agency>Rede Corona-ômica BR MCTI/FINEP affiliated with RedeVírus/MCTI</Agency><Country /></Grant><Grant><GrantID>0494/20; 01.20.0026.00</GrantID><Agency>Laboratórios de Campanha MCTI/FINEP</Agency><Country /></Grant><Grant><GrantID>C1294; C2024-0779, A113</GrantID><Agency>Instituto Todos pela Saúde - ITpS</Agency><Country /></Grant><Grant><GrantID>315592/2021-4, INCT-One CNPq 405786/2022-0</GrantID><Agency>CNPq</Agency><Country /></Grant><Grant><GrantID>0494/20 01.20.0026.00</GrantID><Agency>FINEP</Agency><Country /></Grant><Grant><GrantID>001</GrantID><Agency>CAPES</Agency><Country /></Grant><Grant><GrantID>APQ-02826-24; 001/2024; BPD-00820-2</GrantID><Agency>FAPEMIG</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">VOC Omicron</Keyword><Keyword MajorTopicYN="N">epidemiological scenario</Keyword><Keyword MajorTopicYN="N">genomic surveillance</Keyword><Keyword MajorTopicYN="N">subvariants</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39338420</ArticleId><ArticleId IdType="pmc">PMC11434267</ArticleId><ArticleId IdType="doi">10.3390/microorganisms12091745</ArticleId><ArticleId IdType="pii">microorganisms12091745</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brasil Coronavírus—Brasil 2024.  [(accessed on 15 April 2024)]; Available online:  https://covid.saude.gov.br/</Citation></Reference><Reference><Citation>De Menezes M.T., Moreira F.R.R., Whittaker C., Santos F.M., Queiroz D.C., Geddes V., Fonseca P.L.C., De Jesus J.G., Mendes-Oliveira F., Reis-Souza V., et al. Dynamics of Early Establishment of SARS-CoV-2 VOC Omicron Lineages in Minas Gerais, Brazil. Viruses. 2023;15:585. doi: 10.3390/v15020585.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020585</ArticleId><ArticleId IdType="pmc">PMC9962645</ArticleId><ArticleId IdType="pubmed">36851799</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao K., Tzou P.L., Nouhin J., Gupta R.K., de Oliveira T., Kosakovsky Pond S.L., Fera D., Shafer R.W. The Biological and Clinical Significance of Emerging SARS-CoV-2 Variants. Nat. Rev. Genet. 2021;22:757–773. doi: 10.1038/s41576-021-00408-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-021-00408-x</ArticleId><ArticleId IdType="pmc">PMC8447121</ArticleId><ArticleId IdType="pubmed">34535792</ArticleId></ArticleIdList></Reference><Reference><Citation>Markov P.V., Ghafari M., Beer M., Lythgoe K., Simmonds P., Stilianakis N.I., Katzourakis A. The Evolution of SARS-CoV-2. Nat. Rev. Microbiol. 2023;21:361–379. doi: 10.1038/s41579-023-00878-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-023-00878-2</ArticleId><ArticleId IdType="pubmed">37020110</ArticleId></ArticleIdList></Reference><Reference><Citation>Candido D.D.S., Watts A., Abade L., Kraemer M.U.G., Pybus O.G., Croda J., De Oliveira W., Khan K., Sabino E.C., Faria N.R. Routes for COVID-19 Importation in Brazil. J. Travel Med. 2020;27:taaa042. doi: 10.1093/jtm/taaa042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taaa042</ArticleId><ArticleId IdType="pmc">PMC7184379</ArticleId><ArticleId IdType="pubmed">32211799</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva A.V.F.G., Menezes D., Moreira F.R.R., Torres O.A., Fonseca P.L.C., Moreira R.G., Alves H.J., Alves V.R., Amaral T.M.D.R., Coelho A.N., et al. Seroprevalence, Prevalence, and Genomic Surveillance: Monitoring the Initial Phases of the SARS-CoV-2 Pandemic in Betim, Brazil. Front. Microbiol. 2022;13:799713. doi: 10.3389/fmicb.2022.799713.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.799713</ArticleId><ArticleId IdType="pmc">PMC8859412</ArticleId><ArticleId IdType="pubmed">35197952</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria N.R., Mellan T.A., Whittaker C., Claro I.M., Candido D.D.S., Mishra S., Crispim M.A.E., Sales F.C.S., Hawryluk I., McCrone J.T., et al. Genomics and Epidemiology of the P.1 SARS-CoV-2 Lineage in Manaus, Brazil. Science. 2021;372:815–821. doi: 10.1126/science.abh2644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abh2644</ArticleId><ArticleId IdType="pmc">PMC8139423</ArticleId><ArticleId IdType="pubmed">33853970</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovanetti M., Slavov S.N., Fonseca V., Wilkinson E., Tegally H., Patané J.S.L., Viala V.L., San E.J., Rodrigues E.S., Santos E.V., et al. Genomic Epidemiology of the SARS-CoV-2 Epidemic in Brazil. Nat. Microbiol. 2022;7:1490–1500. doi: 10.1038/s41564-022-01191-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-022-01191-z</ArticleId><ArticleId IdType="pmc">PMC9417986</ArticleId><ArticleId IdType="pubmed">35982313</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca P.L.C., Moreira F.R.R., De Souza R.M., Guimarães N.R., Carvalho N.O., Adelino T.E.R., Alves H.J., Alvim L.B., Candido D.S., Coelho H.P., et al. Tracking the Turnover of SARS-CoV-2 VOCs Gamma to Delta in a Brazilian State (Minas Gerais) with a High-Vaccination Status. Virus Evol. 2022;8:veac064. doi: 10.1093/ve/veac064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac064</ArticleId><ArticleId IdType="pmc">PMC9384558</ArticleId><ArticleId IdType="pubmed">35996592</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcantara L.C.J., Nogueira E., Shuab G., Tosta S., Fristch H., Pimentel V., Souza-Neto J.A., Coutinho L.L., Fukumasu H., Sampaio S.C., et al. SARS-CoV-2 Epidemic in Brazil: How the Displacement of Variants Has Driven Distinct Epidemic Waves. Virus Res. 2022;315:198785. doi: 10.1016/j.virusres.2022.198785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2022.198785</ArticleId><ArticleId IdType="pmc">PMC9022374</ArticleId><ArticleId IdType="pubmed">35461905</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamarca A.P., Souza U.J.B.D., Moreira F.R.R., Almeida L.G.P.D., Menezes M.T.D., Souza A.B.D., Ferreira A.C.D.S., Gerber A.L., Lima A.B.D., Guimarães A.P.D.C., et al. The Omicron Lineages BA.1 and BA.2 (Betacoronavirus SARS-CoV-2) Have Repeatedly Entered Brazil through a Single Dispersal Hub. Viruses. 2023;15:888. doi: 10.3390/v15040888.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040888</ArticleId><ArticleId IdType="pmc">PMC10146814</ArticleId><ArticleId IdType="pubmed">37112869</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva J.D.P., Lima A.B.D., Alvim L.B., Malta F.S.V., Mendonça C.P.T.B., Carvalho A.H.B.D., Rios J.S.H., Fonseca P.L.C., Queiroz D.C., Santos L.C.G.D.A.E., et al. Epidemiological Surveillance Reveals the Rise and Establishment of the Omicron SARS-CoV-2 Variant in Brazil. Viruses. 2023;15:1017. doi: 10.3390/v15041017.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15041017</ArticleId><ArticleId IdType="pmc">PMC10145299</ArticleId><ArticleId IdType="pubmed">37112997</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhi H., Teng Y. The Outbreak of SARS-CoV-2 Omicron Lineages, Immune Escape, and Vaccine Effectivity. J. Med. Virol. 2023;95:e28138. doi: 10.1002/jmv.28138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28138</ArticleId><ArticleId IdType="pmc">PMC9538491</ArticleId><ArticleId IdType="pubmed">36097349</ArticleId></ArticleIdList></Reference><Reference><Citation>BRASIL Guia de Vigilância Genômica Do SARS-CoV-2-Uma Abordagem Epidemiológica e Laboratorial 2023.  [(accessed on 10 February 2024)]; Available online:  https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/comunicacao/guia-de-vigilancia-genomica-do-sars-cov-2-uma-abordagem-epidemiologica-e-laboratorial/view.</Citation></Reference><Reference><Citation>BRASIL Boletim Epidemiológico N° 162—Boletim COE Coronavírus 2024. Ministério da Saúde; Brasilia, Brazil: 2024.</Citation></Reference><Reference><Citation>Paula-Júnior W.D., Nascimento R.C.R.M.D., Matiles R.S., Lima-Neto F.F.D., Leles M.C.R., Guimarães H.N., Grabe-Guimarães A. COVID-19 in Medium-Sized Municipalities in the 14 Health Macro-Regions of Minas Gerais, Brazil. Braz. J. Med. Biol. Res. 2021;54:e11191. doi: 10.1590/1414-431x2021e11191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1414-431x2021e11191</ArticleId><ArticleId IdType="pmc">PMC8389611</ArticleId><ArticleId IdType="pubmed">34431872</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogels C.B.F., Breban M.I., Ott I.M., Alpert T., Petrone M.E., Watkins A.E., Kalinich C.C., Earnest R., Rothman J.E., Goes De Jesus J., et al. Multiplex qPCR Discriminates Variants of Concern to Enhance Global Surveillance of SARS-CoV-2. PLoS Biol. 2021;19:e3001236. doi: 10.1371/journal.pbio.3001236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001236</ArticleId><ArticleId IdType="pmc">PMC8133773</ArticleId><ArticleId IdType="pubmed">33961632</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambisia A.W., Mohammed K.S., Makori T.O., Ndwiga L., Mburu M.W., Morobe J.M., Moraa E.O., Musyoki J., Murunga N., Mwangi J.N., et al. Optimization of the SARS-CoV-2 ARTIC Network V4 Primers and Whole Genome Sequencing Protocol. Front. Med. 2022;9:836728. doi: 10.3389/fmed.2022.836728.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.836728</ArticleId><ArticleId IdType="pmc">PMC8891481</ArticleId><ArticleId IdType="pubmed">35252269</ArticleId></ArticleIdList></Reference><Reference><Citation>DNA Pipelines R&amp;D. Farr B., Rajan D., Dawson E., Shirley L., Quail M., Park N., Bronner I.F., Goodwin S., Thurston S., et al. COVID-19 ARTIC v4.1 Illumina Library Construction and Sequencing Protocol—Tailed Method V2 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.17504/protocols.io.j8nlk4b36g5r/v2</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreira F.R.R., D’arc M., Mariani D., Herlinger A.L., Schiffler F.B., Rossi Á.D., Leitão I.d.C., Miranda T.d.S., Cosentino M.A.C., Tôrres M.C.d.P., et al. Epidemiological Dynamics of SARS-CoV-2 VOC Gamma in Rio de Janeiro, Brazil. Virus Evol. 2021;7:veab087. doi: 10.1093/ve/veab087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veab087</ArticleId><ArticleId IdType="pmc">PMC8522364</ArticleId><ArticleId IdType="pubmed">34725568</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Toole Á., Scher E., Underwood A., Jackson B., Hill V., McCrone J.T., Colquhoun R., Ruis C., Abu-Dahab K., Taylor B., et al. Assignment of Epidemiological Lineages in an Emerging Pandemic Using the Pangolin Tool. Virus Evol. 2021;7:veab064. doi: 10.1093/ve/veab064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veab064</ArticleId><ArticleId IdType="pmc">PMC8344591</ArticleId><ArticleId IdType="pubmed">34527285</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksamentov I., Roemer C., Hodcroft E., Neher R. Nextclade: Clade Assignment, Mutation Calling and Quality Control for Viral Genomes. J. Open Source Softw. 2021;6:3773. doi: 10.21105/joss.03773.</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.03773</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H. Minimap2: Pairwise Alignment for Nucleotide Sequences. Bioinformatics. 2018;34:3094–3100. doi: 10.1093/bioinformatics/bty191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty191</ArticleId><ArticleId IdType="pmc">PMC6137996</ArticleId><ArticleId IdType="pubmed">29750242</ArticleId></ArticleIdList></Reference><Reference><Citation>Minh B.Q., Schmidt H.A., Chernomor O., Schrempf D., Woodhams M.D., Von Haeseler A., Lanfear R. IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era. Mol. Biol. Evol. 2020;37:1530–1534. doi: 10.1093/molbev/msaa015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msaa015</ArticleId><ArticleId IdType="pmc">PMC7182206</ArticleId><ArticleId IdType="pubmed">32011700</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaut A., Drummond A.J., Xie D., Baele G., Suchard M.A. Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7. Syst. Biol. 2018;67:901–904. doi: 10.1093/sysbio/syy032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sysbio/syy032</ArticleId><ArticleId IdType="pmc">PMC6101584</ArticleId><ArticleId IdType="pubmed">29718447</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosta S., Moreno K., Schuab G., Fonseca V., Segovia F.M.C., Kashima S., Elias M.C., Sampaio S.C., Ciccozzi M., Alcantara L.C.J., et al. Global SARS-CoV-2 Genomic Surveillance: What We Have Learned (so Far) Infect. Genet. Evol. 2023;108:105405. doi: 10.1016/j.meegid.2023.105405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2023.105405</ArticleId><ArticleId IdType="pmc">PMC9847326</ArticleId><ArticleId IdType="pubmed">36681102</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Azman A.S., Chen X., Zou J., Tian Y., Sun R., Xu X., Wu Y., Lu W., Ge S., et al. Global Landscape of SARS-CoV-2 Genomic Surveillance and Data Sharing. Nat. Genet. 2022;54:499–507. doi: 10.1038/s41588-022-01033-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01033-y</ArticleId><ArticleId IdType="pmc">PMC9005350</ArticleId><ArticleId IdType="pubmed">35347305</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardeau-Serra L., Nguyen-Huynh A., Sponagel L., Sernizon Guimarães N., Teixeira De Aguiar R.A., Soriano Marcolino M. The COVID-19 Vaccination Strategy in Brazil—A Case Study. Epidemiologia. 2021;2:338–359. doi: 10.3390/epidemiologia2030026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/epidemiologia2030026</ArticleId><ArticleId IdType="pmc">PMC9620893</ArticleId><ArticleId IdType="pubmed">36417230</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . COVID-19 Cases. WHO; Geneva, Switzerland: 2024.</Citation></Reference><Reference><Citation>Tian D., Sun Y., Xu H., Ye Q. The Emergence and Epidemic Characteristics of the Highly Mutated SARS-CoV-2 Omicron Variant. J. Med. Virol. 2022;94:2376–2383. doi: 10.1002/jmv.27643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27643</ArticleId><ArticleId IdType="pmc">PMC9015498</ArticleId><ArticleId IdType="pubmed">35118687</ArticleId></ArticleIdList></Reference><Reference><Citation>Secretaria do Estado de Saúde de Minas Gerais (SES-MG) Painel Vacinômetro Coronavírus 2023.  [(accessed on 15 December 2023)]; Available online:  https://coronavirus.saude.mg.gov.br/vacinometro.</Citation></Reference><Reference><Citation>Adamoski D., Baura V.A.D., Rodrigues A.C., Royer C.A., Aoki M.N., Tschá M.K., Bonatto A.C., Wassem R., Nogueira M.B., Raboni S.M., et al. SARS-CoV-2 Delta and Omicron Variants Surge in Curitiba, Southern Brazil, and Its Impact on Overall COVID-19 Lethality. Viruses. 2022;14:809. doi: 10.3390/v14040809.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14040809</ArticleId><ArticleId IdType="pmc">PMC9027352</ArticleId><ArticleId IdType="pubmed">35458539</ArticleId></ArticleIdList></Reference><Reference><Citation>Viana R., Moyo S., Amoako D.G., Tegally H., Scheepers C., Althaus C.L., Anyaneji U.J., Bester P.A., Boni M.F., Chand M., et al. Rapid Epidemic Expansion of the SARS-CoV-2 Omicron Variant in Southern Africa. Nature. 2022;603:679–686. doi: 10.1038/s41586-022-04411-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04411-y</ArticleId><ArticleId IdType="pmc">PMC8942855</ArticleId><ArticleId IdType="pubmed">35042229</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegally H., Moir M., Everatt J., Giovanetti M., Scheepers C., Wilkinson E., Subramoney K., Makatini Z., Moyo S., Amoako D.G., et al. Emergence of SARS-CoV-2 Omicron Lineages BA.4 and BA.5 in South Africa. Nat. Med. 2022;28:1785–1790. doi: 10.1038/s41591-022-01911-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01911-2</ArticleId><ArticleId IdType="pmc">PMC9499863</ArticleId><ArticleId IdType="pubmed">35760080</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz D.C., Carobin N.V., De Araújo E Santos L.C.G., Fonseca P.L.C., Braga-Paz I.L., Dias R.C., Ferreira J.G.G., Freitas T.R., Menezes D., Nolasco S.C.V.M., et al. SARS-CoV-2 Omicron BA.1, BA.2, and XAG Identification during Routine Surveillance on a University Campus in Belo Horizonte, Brazil, 2022. Braz. J. Microbiol. 2022;53:2009–2014. doi: 10.1007/s42770-022-00848-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42770-022-00848-5</ArticleId><ArticleId IdType="pmc">PMC9589559</ArticleId><ArticleId IdType="pubmed">36272063</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Q., Zeng J., Tang K., Long H., Zhang C., Zhang J., Tang J., Xin Y., Zheng J., Sun L., et al. Variation in Synonymous Evolutionary Rates in the SARS-CoV-2 Genome. Front. Microbiol. 2023;14:1136386. doi: 10.3389/fmicb.2023.1136386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1136386</ArticleId><ArticleId IdType="pmc">PMC10034387</ArticleId><ArticleId IdType="pubmed">36970680</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramazzotti D., Angaroni F., Maspero D., Mauri M., D’Aliberti D., Fontana D., Antoniotti M., Elli E.M., Graudenzi A., Piazza R. Large-Scale Analysis of SARS-CoV-2 Synonymous Mutations Reveals the Adaptation to the Human Codon Usage during the Virus Evolution. Virus Evol. 2022;8:veac026. doi: 10.1093/ve/veac026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac026</ArticleId><ArticleId IdType="pmc">PMC8971538</ArticleId><ArticleId IdType="pubmed">35371557</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke H., Chang M., Marasco W. Immune Evasion of SARS-CoV-2 Omicron Subvariants. Vaccines. 2022;10:1545. doi: 10.3390/vaccines10091545.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10091545</ArticleId><ArticleId IdType="pmc">PMC9501521</ArticleId><ArticleId IdType="pubmed">36146623</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Guo Y., Iketani S., Nair M.S., Li Z., Mohri H., Wang M., Yu J., Bowen A.D., Chang J.Y., et al. Antibody Evasion by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4 and BA.5. Nature. 2022;608:603–608. doi: 10.1038/s41586-022-05053-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05053-w</ArticleId><ArticleId IdType="pmc">PMC9385487</ArticleId><ArticleId IdType="pubmed">35790190</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan M., Saied A.A., Mitra S., Alhumaydhi F.A., Emran T.B., Wilairatana P. Omicron Variant (B.1.1.529) and Its Sublineages: What Do We Know so Far amid the Emergence of Recombinant Variants of SARS-CoV-2? Biomed. Pharmacother. 2022;154:113522. doi: 10.1016/j.biopha.2022.113522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.113522</ArticleId><ArticleId IdType="pmc">PMC9376347</ArticleId><ArticleId IdType="pubmed">36030585</ArticleId></ArticleIdList></Reference><Reference><Citation>Mistry P., Barmania F., Mellet J., Peta K., Strydom A., Viljoen I.M., James W., Gordon S., Pepper M.S. SARS-CoV-2 Variants, Vaccines, and Host Immunity. Front. Immunol. 2022;12:809244. doi: 10.3389/fimmu.2021.809244.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.809244</ArticleId><ArticleId IdType="pmc">PMC8761766</ArticleId><ArticleId IdType="pubmed">35046961</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca P.L.C., Malta F.S.V., Braga-Paz I., Do Prado Silva J., De Souza C.S.A., De Aguiar R.S., Zauli D.A.G., De Souza R.P. SARS-CoV-2 Reinfection Rate before and after VOC Omicron Emergence: A Retrospective Study in Brazil. Braz. J. Microbiol. 2024 doi: 10.1007/s42770-024-01467-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42770-024-01467-y</ArticleId><ArticleId IdType="pubmed">39048913</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>